Current evidence suggests that loss of Lys 160 sumoylation impairs DAXX recruitment to PML/RARA, thereby interfering with its transcriptional repressor activity; however future work is needed to clarify the involvement of different SUMO isoforms in this process, both ex vivo and in vivo in APL mouse models. Here, RARA is linked to acute promyelocytic leukemia.